De Ravin et al. (22) used CRISPR-Cas9 to repair a mutation in the CYBB gene of CD34+ hematopoietic stem and progenitor cells (HSPCs) from patients with the immunodeficiency disorder X-CGD. Here, CD34 is linked to chronic granulomatous disease.